Things definitely improving.
Another quarter where cash receipts > product and operating costs, unlike the Carestream days.
Cash still tight. Add back the R&D rebate and they are burning around $2m with just over $5m in the bank.
So getting better but need to get a wriggle on. Hopefully win a few contracts and get the share price up.
Onwards and upwards
